Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HAIN CELESTIAL GROUP INCHAIN · Entity 7055 | Director | October 30, 2025 | November 03, 2025 |
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Director | August 04, 2026 | August 05, 2026 |
| Purple Innovation, Inc.PRPL · Entity 7764 | Director | April 27, 2023 | May 01, 2023 |
| Spirit Aviation Holdings, Inc.SAVE · Entity 77286 | Director | January 24, 2024 | January 26, 2024 |
| TIVITY HEALTH, INC.TVTY · Entity 125776 | Director · President and COO | October 15, 2019 | October 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HAIN CELESTIAL GROUP INC
Report date October 30, 2025 · Filed November 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 402,958 |
Reported balance
After 2025-10-30 transaction · row 1
1 source rowRow 1 · 2025-10-30 · Grant · Acquired 114,729 · Balance 402,958 F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Prestige Consumer Healthcare Inc.
Report date August 04, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 19,514 |
Reported balance
After 2026-08-04 transaction · row 1
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 2,981 · Balance 19,514 F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
Purple Innovation, Inc.
Report date April 27, 2023 · Filed May 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Proportional Representation Preferred Linked StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-04-27 transaction · row 1
1 source rowRow 1 · 2023-04-27 · Other · Disposed 423.89 · Balance 0 F1: The Proportional Representation Preferred Linked Stock was originally issued in a stock dividend to all holders of the issuer's Class A common stock and Class B common stock on February 24, 2023. The shares of Proportional Representation Preferred Linked Stock were redeemed by the issuer in accordance with their terms on April 27, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The Proportional Representation Preferred Linked Stock was originally issued in a stock dividend to all holders of the issuer's Class A common stock and Class B common stock on February 24, 2023. The shares of Proportional Representation Preferred Linked Stock were redeemed by the issuer in accordance with their terms on April 27, 2023.
Spirit Aviation Holdings, Inc.
Report date January 24, 2024 · Filed January 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,702 |
Reported balance
After 2024-01-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-01-24 · Grant · Acquired 16,901 · Balance 44,702 F1: Grant of restricted stock units, vesting 100% on January 24, 2025. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units, vesting 100% on January 24, 2025.
F2: Includes restricted stock units.
TIVITY HEALTH, INC.
Report date October 15, 2019 · Filed October 24, 2019 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 641,158 |
Reported balance
After 2019-10-15 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-10-15 · Tax withholding · Disposed 88,301 · Balance 641,158 F1: Reflects 88,301 shares withheld to cover the payment of taxes following the distribution of the following awards by the Issuer in connection with the Issuer's acquisition of Nutrisystem, Inc. on March 8, 2019: (i) 84,869 shares of restricted stock and (ii) 118,211 restricted stock units. F2: Reflects a decrease of 104,340 shares previously reported as withheld to cover the payment of taxes on the original Form 4 filed on October 17, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects 88,301 shares withheld to cover the payment of taxes following the distribution of the following awards by the Issuer in connection with the Issuer's acquisition of Nutrisystem, Inc. on March 8, 2019: (i) 84,869 shares of restricted stock and (ii) 118,211 restricted stock units.
F2: Reflects a decrease of 104,340 shares previously reported as withheld to cover the payment of taxes on the original Form 4 filed on October 17, 2019.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NUTRI SYSTEM INC /DE/
Report date March 08, 2019 · Filed March 11, 2019
Section 16 reporting ended · disclosed 2019-03-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 500,140 · Balance 0 F1: This amount includes 41,440 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F2: This amount includes 68,376 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
| Common StockSEC Table I · non-derivative | Direct | 20,043 |
Reported balance
After 2019-03-08 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2019-03-08 · Grant · Acquired 20,043 · Balance 20,043 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 12,665 |
Reported balance
After 2019-03-08 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2019-03-08 · Grant · Acquired 12,665 · Balance 12,665 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 20,864 |
Reported balance
After 2019-03-08 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2019-03-08 · Grant · Acquired 20,864 · Balance 20,864 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Common StockSEC Table I · non-derivative | Direct | 57,720 |
Reported balance
After 2019-03-08 transaction · row 5
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 5 · 2019-03-08 · Grant · Acquired 57,720 · Balance 57,720 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. |
| Common StockSEC Table I · non-derivative | Direct | 90,132 |
Reported balance
After 2019-03-08 transaction · row 6
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 6 · 2019-03-08 · Grant · Acquired 90,132 · Balance 90,132 F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $14.95 · Expires 2021-03-20 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-08 · Disposition to issuer · Disposed 20,043 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $21.64 · Expires 2022-12-31 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-08 · Disposition to issuer · Disposed 12,665 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $20.94 · Expires 2023-01-04 | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-03-08 · Disposition to issuer · Disposed 20,864 · Balance 0 F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder. F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-03-08 · Disposition to issuer · Disposed 57,720 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-03-08 · Disposition to issuer · Disposed 90,132 · Balance 0 F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved. F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder. F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement); F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This amount includes 41,440 shares of Issuer Common Stock subject to restricted stock awards that, subject to the terms of the Issuer's Amended and Restated 2008 Long-Term Incentive Plan, as amended (the "Plan") and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.
F2: This amount includes 68,376 shares of Issuer Common Stock subject to PRSUs that, subject to the terms of the Plan and the applicable award agreement issued thereunder, were previously granted to the Reporting Person and, as of the Effective Time, were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4.
F3: As of the effective time (the "Effective Time") of the transactions contemplated by the Agreement and Plan of Merger, dated December 9, 2018, by and among the Issuer, Tivity Health, Inc. ("Tivity Health"), and Sweet Acquisition Sub Inc., a wholly owned subsidiary of Tivity Health (the "Merger Agreement"), (i) each share of the Issuer's common stock, $0.001 par value per share ("Issuer Common Stock") held by the Reporting Person was converted into the right to receive (a) $38.75 in cash and (b) 0.2141 shares of Tivity Health common stock, par value $0.001 per share ("Tivity Health Common Stock"), plus cash in lieu of a fractional share of Tivity Health Common Stock; (ii) each option to purchase Issuer Common Stock held by the Reporting Person was cancelled and converted into the right to receive, in respect of each Net Option Share (as defined in the Merger Agreement) subject to each option, an amount in cash equal to the Merger Consideration Value (as defined in the Merger Agreement);
F4: Cont'd from Footnote 3: (iii) each restricted stock award held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such restricted stock awards multiplied by (b) the Equity Award Exchange Ratio (as defined in the Merger Agreement), rounded to the nearest whole number of shares of Tivity Health Common Stock; and (iv) each performance-based restricted stock unit ("PRSUs") held by the Reporting Person was converted into the right to receive an amount in time-vesting restricted Tivity Health Common Stock equal to the product of (a) the number of shares of Issuer Common Stock subject to such PRSUs (based on the actual or maximum performance level achievable by the Issuer as provided in the Merger Agreement) multiplied by (b) the Equity Award Exchange Ratio, rounded to the nearest whole number of shares of Tivity Health Common Stock.
F5: At grant, this stock option represented the right to purchase shares of Issuer Common Stock subject to the terms of the Plan and the applicable award agreement issued thereunder.
F6: As of the Effective Time, pursuant to the terms of the Merger Agreement, this stock option was cancelled and converted into the right to receive, in respect of each Net Option Share subject to this stock option, an amount in cash equal to the Merger Consideration Value.
F7: These PRSUs represented the contingent right to receive shares of Issuer Common Stock subject to the Issuer's achievement of performance conditions, subject to the terms of the Plan and the applicable award agreement issued thereunder.
F8: As of the Effective Time, pursuant to the terms of the Merger Agreement, such PRSUs were converted into the right to receive an amount of time-vesting restricted Tivity Health Common Stock as described in Footnotes 3 and 4, assuming maximum performance was achieved.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2017 Filed Mar 22, 2017 17:04 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 2,880 | $53.55 | $154,224.00 |
DisclosureSEC source: 0001209191-17-022338 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,748 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 17:04 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 2,399 | $53.95 | $129,426.05 |
DisclosureSEC source: 0001209191-17-022338 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,628 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 16:12 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 30,000 | $48.11 | $1,443,198.00 |
DisclosureSEC source: 0001209191-17-019832 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,027 Read SEC document |
| February 28, 2017 Filed Jun 16, 2017 16:11 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 74,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040465 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,824 F1 · security: Restricted stock units were granted upon the achievement of certain specified performance goals and will vest, subject to continued employment, on December 31, 2017. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 824 | $0.00 Strike: $21.64 | $0.00 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · derivative · entry 11 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,897 Underlying: Common Shares · 824 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 7,370 | $0.00 Strike: $20.94 | $0.00 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · derivative · entry 10 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,721 Underlying: Common Shares · 7,370 shares Expires 2023-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 21,806 | $0.00 Strike: $18.98 | $0.00 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · derivative · entry 9 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,091 Underlying: Common Shares · 21,806 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 11,980 | $35.75 | $428,285.00 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 8 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,027 F6 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 25,993 | $35.75 | $929,249.75 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 7 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,007 F5 · security: Shares were granted upon the achievement of certain specified performance goals. F5 · shares: Shares were granted upon the achievement of certain specified performance goals. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 824 | $34.98 | $28,827.23 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 6 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,014 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to $35.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 824 | $21.64 | $17,831.36 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 5 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 7,370 | $35.46 | $261,354.94 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 4 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,014 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $35.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 7,370 | $20.94 | $154,327.80 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 21,806 | $35.47 | $773,413.03 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,014 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $35.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 16:23 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 21,806 | $18.98 | $413,877.88 |
DisclosureSEC source: 0001209191-17-012102 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 21:38 UTC | Spirit Aviation Holdings, Inc. SAVE · Entity 77286 | GrantCommon Stock | 1,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001498710-17-000028 · wf-form4_148546668157339.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,969 F1 · kind: Grant of restricted stock units, vesting on January 24, 2018. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 30,000 | $0.00 Strike: $21.64 | $0.00 |
DisclosureSEC source: 0001209191-17-004828 · doc4.xml · derivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,897 Underlying: Common Shares · 30,000 shares Expires 2022-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 30,000 | $35.23 | $1,056,753.00 |
DisclosureSEC source: 0001209191-17-004828 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,014 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.9500 to $35.4750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 16:13 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 30,000 | $21.64 | $649,200.00 |
DisclosureSEC source: 0001209191-17-004828 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 16:35 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 2,751 | $36.75 | $101,099.25 |
DisclosureSEC source: 0001209191-17-002664 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,014 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 17:19 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | GrantCommon stock | 34,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001201 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,765 F2 · shares: Restricted shares were granted on January 3, 2017. Shares vest over three years in equal installments on January 3rd of each year. Price per share on day of grant is $35.10. F2 · price: Restricted shares were granted on January 3, 2017. Shares vest over three years in equal installments on January 3rd of each year. Price per share on day of grant is $35.10. Read SEC document |
| January 02, 2017 Filed Jan 4, 2017 17:19 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Tax withholdingCommon stock | 2,594 | $34.65 | $89,882.10 |
DisclosureSEC source: 0001209191-17-001201 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,577 F1 · shares: Withholding of common stock to cover tax liability. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 5,071 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · derivative · entry 9 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,897 Underlying: Common Shares · 5,071 shares Expires 2019-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,071 | $35.55 | $180,274.05 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · nonDerivative · entry 6 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,171 Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 5,071 | $9.07 | $45,993.97 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · nonDerivative · entry 5 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 5,000 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · derivative · entry 8 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,968 Underlying: Common Shares · 5,000 shares Expires 2019-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 19,940 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · derivative · entry 7 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,968 Underlying: Common Shares · 19,940 shares Expires 2019-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 5,000 | $36.65 | $183,231.50 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · nonDerivative · entry 4 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,171 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.3500 to $37.2000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 19,940 | $36.30 | $723,780.13 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · nonDerivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,171 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.4000 to $37.2000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 5,000 | $9.07 | $45,350.00 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2016 Filed Dec 14, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 19,940 | $7.31 | $145,761.40 |
DisclosureSEC source: 0001209191-16-155138 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 16:18 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 25,000 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-16-151705 · doc4.xml · derivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,908 Underlying: Common Shares · 25,000 shares Expires 2019-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 16:18 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 25,000 | $35.81 | $895,167.50 |
DisclosureSEC source: 0001209191-16-151705 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,171 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were gifted in multiple transactions at prices ranging from $35.3500 to $36.0500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 16:18 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 25,000 | $7.31 | $182,750.00 |
DisclosureSEC source: 0001209191-16-151705 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2016 Filed Oct 21, 2016 16:06 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 19,150 | $0.00 Strike: $8.52 | $0.00 |
DisclosureSEC source: 0001209191-16-146581 · doc4.xml · derivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,908 Underlying: Common Shares · 19,150 shares Expires 2020-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2016 Filed Oct 21, 2016 16:06 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 19,150 | $31.15 | $596,489.95 |
DisclosureSEC source: 0001209191-16-146581 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,171 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.9500 to $31.4000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 20, 2016 Filed Oct 21, 2016 16:06 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 19,150 | $8.52 | $163,158.00 |
DisclosureSEC source: 0001209191-16-146581 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock options, .001 (right to buy) · Derivative | 25,000 | $0.00 Strike: $8.52 | $0.00 |
DisclosureSEC source: 0001209191-16-142443 · doc4.xml · derivative · entry 3 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,058 Underlying: Common Shares · 25,000 shares Expires 2020-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options vest in four equal tranches on the first four anniversaries of the date of grant. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | SaleCommon stock | 25,000 | $28.62 | $715,617.50 |
DisclosureSEC source: 0001209191-16-142443 · doc4.xml · nonDerivative · entry 2 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,171 F1 · kind: Sale pursuant to a 10(b)5-1 plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.2600 to $28.9000, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 16:03 UTC | NUTRI SYSTEM INC /DE/ NTRI · Entity 159276 | Exercise / conversionCommon stock | 25,000 | $8.52 | $213,000.00 |
DisclosureSEC source: 0001209191-16-142443 · doc4.xml · nonDerivative · entry 1 ZIER DAWN M. · CIK 0001562083 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.